APA citiranje

Caon, C., Namey, M., Meyer, C., Mayer, L., Oyuela, P., Margolin, D. H., & Rizzo, M. (2015). Prevention and Management of Infusion-Associated Reactions in the Comparison of Alemtuzumab and Rebif(®) Efficacy in Multiple Sclerosis (CARE-MS) Program. Int J MS Care.

Citação norma Chicago

Caon, Christina, Marie Namey, Cathy Meyer, Lori Mayer, Pedro Oyuela, David H. Margolin, and Marco Rizzo. "Prevention and Management of Infusion-Associated Reactions in the Comparison of Alemtuzumab and Rebif(®) Efficacy in Multiple Sclerosis (CARE-MS) Program." Int J MS Care 2015.

MLA citiranje

Caon, Christina, et al. "Prevention and Management of Infusion-Associated Reactions in the Comparison of Alemtuzumab and Rebif(®) Efficacy in Multiple Sclerosis (CARE-MS) Program." Int J MS Care 2015.

Opozorilo: Ti citati niso vedno 100% točni.